Clinical Trial Update: Toripalimab With Preoperative Chemoradiotherapy for LA-EGJ [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating toripalimab with preoperative chemoradiotherapy for locally advanced esophagogastric junction cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Junction Cancer

Drugs mentioned

• Toripalimab (Toripalimab)

Snippet

Sponsor: Peking University | Conditions: PD-1, Chemoradiotherapy | Phase 1, Phase 2 | Status: UNKNOWN